v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Revenue $ 2 $ 7
Operating expenses:    
Research and development 36,604 43,447
General and administrative 9,555 14,046
Other operating income, net (1,896) (119)
Total operating expenses 44,263 57,374
Loss from operations (44,261) (57,367)
Interest income, net 2,194 3,862
Other income, net 17,914 1,310
Total other income, net 20,108 5,172
Net loss (24,153) (52,195)
Other comprehensive loss:    
Net unrealized loss on marketable securities (251) (133)
Comprehensive loss $ (24,404) $ (52,328)
Net loss per common share, basic (in dollars per share) [1] $ (1.10) $ (3.54)
Net loss per common share, diluted (in dollars per share) [1] $ (1.10) $ (3.54)
Weighted-average shares used to compute net loss per common share, basic (in shares) [1] 21,876 14,755
Weighted-average shares used to compute net loss per common share, diluted (in shares) [1] 21,876 14,755
[1] Amounts previously reported have been retroactively adjusted to reflect the 1-for-20 reverse stock split effected on May 30, 2025. See Note 2.